ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
ASEAN Mosquito-Borne Infections Molecular Testing Market size was valued at USD 41.21 Million in 2021 and is projected to reach USD 74.86 Million by the end of 2030, growing at a CAGR of 5.76% from 2023 to 2030.
There has been a significant focus on the early-stage diagnosis of infection, viral load measurement can be done using the molecular detection method, which is a driving factor supporting the growth of the ASEAN mosquito-borne infections molecular testing market. The ASEAN Mosquito-Borne Infections Molecular Testing Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Insects aren't all bad, but some can be real pests and even dangerous to our health. Take mosquitoes, for example. These little buzzers can transmit diseases, making them a serious threat. We're talking about nasty stuff like Dengue Haemorrhagic Fever (DHF) and chikungunya, spread by Aedes aegypti and Aedes albopictus mosquitoes, plus Malaria and a whole host of other illnesses. With so many reports of mosquito-borne diseases and the impact they have, we're putting a lot of effort into fighting back. One key strategy is getting better at diagnosis, and that's where molecular testing comes in. Learn more about mosquito-borne diseases here.
Southeast Asia is a fascinating place where social, ecological, biological, and technological things are all mixed up, helping tiny microbes find new homes and opportunities. Think about itpopulations growing and moving around, cities popping up, how we grow and get our food changing, and how we use the land. Plus, things like clean water, sanitation, and even how our health systems fight disease (and sometimes create drug resistance!) all play a part. This region is home to around 600 million people living in wildly different countries. You've got Laos, which was mostly rural until recently, with an economy of just USD 890 per person. Then there's Singapore, a bustling city-state where the average person makes around USD 37 500! Because of all this, there's a big push to catch infections early. And that's where molecular detection methods come in – they're key for measuring viral loads, and they're really driving the market for mosquito-borne infection testing in the ASEAN region. Take Laos, for example. The government is serious about wiping out malaria by 2030. Even with COVID-19 throwing a wrench in things, they're testing for malaria more than ever, and the number of cases is actually going down! They even launched new guidelines at the end of 2020 to proactively track, test, and treat every single case. All of these efforts are creating exciting opportunities for companies looking to get into the molecular testing market for mosquito-borne illnesses in ASEAN.
However, the costs of preventing or controlling mosquito born infectious disease can seem high when compared to the direct public health benefits of such actions. This can be explained as Nucleic acid tests (NATs) that are known as molecular tests are required to be done in a centralized lab location and require expensive equipment and skilled personnel. Thus, the lack of awareness as well as investments are likely to hamper the growth of ASEAN mosquito borne infections molecular testing market.
To Get a Summarized Market Report By Disease Type-
In 2021, dengue really dominated, snagging a whopping 91.20% of the market – that's USD 33.77 Million! And it's expected to keep growing at a CAGR of 5.89% over the next few years. Speaking of dengue, cases in Southeast Asia jumped by 46% between 2015 and 2019, even though, thankfully, mortality dropped a bit (by 2%). Why are those pesky dengue mosquitoes spreading so much in the region? Well, it's a mix of things. We're talking about rapid population growth, not enough clean water and good ways to store it, plus problems with sewers and garbage disposal. Add in more travel and trade, global warming, changes in how public health is handled, and a rise in really bad outbreaks in big cities, and you've got a perfect storm. To make matters worse, we're seeing lots of dengue cases but not enough long-term solutions for controlling mosquitoes or treating the illness effectively. By the way, if you're feeling sick with dengue, doctors can usually find the virus's RNA in your blood using molecular tests within the first week.
ASEAN Mosquito-Borne Infections Molecular Testing Market, By End-User
• Hospitals And Clinics• Private Commercial Laboratories• Others
To Get a Summarized Market Report By End Users-
In 2021, Hospitals and Clinics dominated the market, grabbing a whopping 54.51% share, which translates to a market value of USD 20.15 Million! And guess what? They're expected to keep growing at a rate of 5.77% each year. Right now, you've got hospital bigwigs wondering if setting up their own molecular diagnostics lab is the smartest move for their organizations and scratching their heads about how to pay for all that fancy molecular diagnostic testing. Of course, they're thinking about bringing in more money and cutting down on expenses. Let's face it, the payback for molecular tests is looking pretty sweet – way better than your run-of-the-mill clinical chemistry, immunoassays, and culture tests. Plus, imagine how much dough they could save by ditching a bunch of those pricey send-out tests just by investing in a molecular testing system!
ASEAN Mosquito-Borne Infections Molecular Testing Market, By Geography
In the global market split, Philippines is dominating region-wise while automated is leading according to type. The Philippines is a string of over 7,100 islands situated in South-Eastern Asia between the South China Sea and the Pacific Ocean. The Philippines, being a fertile, tropical and biodiverse land has evolved as a centre for vector-borne diseases burdening the healthcare sector of the country. Main diseases that are largely spreading their presence in the country are Malaria, Dengue, Lymphatic filariasis, Schistosomiasis and Japanese encephalitis.
Key Players
The presence of prominent ASEAN Mosquito-Borne Infections Molecular Testing market players such as InBios International Inc, NovaTec Immundiagnostica GmbH, Abbott Laboratories, Abnova Corporation, Thermo Fisher Scientific Inc., Certest Biotech SL, F. Hoffmann-La Roche Ltd, OriGene Technologies Inc., and Quest Diagnostics.
Key Developments
• September 2018, InBios received 510k marketing clearance from the FDA for its DENV Detect NS1 ELISA kit for many infections disease.
This antigen detection assay provides presumptive diagnosis of dengue virus from serum samples taken from patients within the first seven days of clinical symptoms consistent with either dengue fever or dengue hemorrhagic fever. The NS1 kit correctly identified 86.6% of patients confirmed positive for dengue NS1 antigen and 97.8% of negative confirmed patient specimens.
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
We take a deep dive into the market using both qualitative and quantitative analysis, breaking it down into segments based on economic and, well, everything else! You'll get clear data on market value (in USD Billion) for each of these segments and sub-segments. Plus, we'll pinpoint which region and segment are predicted to be the rocket ships, seeing the fastest growth and dominating the field. We'll also analyze each region, highlighting product/service consumption and what's driving the market there. Think of it as a geographical treasure map! For the competitive landscape, we'll show you the top players, their market ranking, and all the juicy details—new launches, partnerships, expansions, and acquisitions from the last five years. You'll get extensive company profiles toooverview, insights, product benchmarking, and a good old SWOT analysis. We cover the current and future market outlook, considering recent developments, growth opportunities, drivers, challenges, and restraints in both emerging and developed areas. We also dig into the market's core using Porter's five forces analysis and give you a clear understanding of the Value Chain. Finally, we lay out the market dynamics scenario, highlighting growth opportunities down the road, and offer 6 months of post-sales analyst support – basically, we've got your back!
Customization of the Report
• In case of any  please connect with our sales team, who will ensure that your requirements a
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for ASEAN Mosquito-Borne Infections Molecular Testing Market Size By Disease Type (Dengue, Chikungunya, Malaria), By End Users (Hospitals And Clinics, Private Commercial Laboratories), By Geographic Scope And Forecast
